Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Encap Drug Delivery was a leading UK-based contract development and manufacturing organization specializing in liquid-filled hard capsules for oral drug delivery. The company developed proprietary platforms such as DuoCap™ and ENCODE for targeted or modified release, with capabilities spanning from preclinical to commercial manufacturing. Their expertise included handling high-potency compounds and providing integrated analytical, formulation development, clinical trial supply, and large-scale GMP manufacturing services. In March 2013, the company was acquired by Capsugel; subsequently Capsugel itself became part of Lonza Group AG.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Encap Drug Delivery.